Podcasts

September 2021

Prof. Susan O’Brien about the value of acalabrutinib in CLL

Prof. Susan O’Brien, University of California Irvine, United States

To view this podcast please log in on top of screen.

SUBSCRIBE TO BJH HEMATALKS SERIES

Latest podcasts

September 2024

Exploring Second-Generation BTK Inhibitors in Chronic Lymphocytic Leukemia (CLL)

Dr. Adam Kittai (Icahn School of Medicine, Mount Sinai, New York)

January 2024

PODCASTS

Dr Deeren discusses the latest update in the management of patients with Paroxysmal Nocturnal Hemoglobinuria including the place of the new long acting C5 inhibitor ravulizumab in the treatment algorithm

Dr. Dries Deeren (AZ Delta, Roeselare)

September 2023

Prof. Paolo Ghia discusses the results of a matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia

Prof. Paolo Ghia (Università Vita Salute San Raffaele, Italy)

Top